Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
4.690
+0.170 (3.76%)
Nov 21, 2024, 1:14 PM EST - Market open
Sagimet Biosciences Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Sagimet Biosciences stock have an average target of 21.6, with a low estimate of 6.00 and a high estimate of 32. The average target predicts an increase of 360.55% from the current stock price of 4.69.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SGMT stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 1 | 1 | 1 | 1 | 2 |
Buy | 4 | 4 | 2 | 2 | 2 | 2 |
Hold | 0 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 4 | 4 | 4 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +582.30% | Nov 15, 2024 |
UBS | UBS | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +155.86% | Nov 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +582.30% | Oct 31, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +582.30% | Oct 2, 2024 |
JMP Securities | JMP Securities | Buy Maintains $48 → $32 | Buy | Maintains | $48 → $32 | +582.30% | Aug 15, 2024 |
Financial Forecast
Revenue This Year
n/a
from 2.00M
Revenue Next Year
n/a
EPS This Year
-1.54
from -2.66
EPS Next Year
-3.62
from -1.54
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | ||
Avg | n/a | n/a | n/a | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.21 | -2.12 | -3.36 | ||
Avg | -1.54 | -3.62 | -5.44 | ||
Low | -1.81 | -4.92 | -9.19 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.